Complete Filing Data
Mobile-health Network Solutions reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $2.62 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Mobile-health Network Solutions did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Selling General And Administrative Expense | $2.7M | $4.9M | $1.9M | $615.5K |
| Revenue From Contract With Customer Excluding Assessed Tax | $7.6M | $14.0M | $7.9M | $7.0M |
| Other Nonoperating Income | $130.6K | $81.8K | $47.4K | $62.5K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $163.0K | $139.2K | $396.3K | -$114.4K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent | $163.0K | $139.2K | $396.3K | -$114.4K |
| Operating Expenses | $4.8M | $18.2M | $4.4M | $1.7M |
| Nonoperating Income Expense | $161.3K | $81.8K | $75.3K | $64.8K |
| Net Income Loss | -$3.4M | -$15.6M | -$3.2M | $92.7K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.4M | -$15.6M | -$3.2M | $258.5K |
| Gross Profit | $1.3M | $2.5M | $1.1M | $1.9M |
| Cost Of Revenue | $6.4M | $11.4M | $6.8M | $5.1M |
| Comprehensive Income Net Of Tax | -$3.2M | -$15.5M | -$2.8M | -$21.7K |
| Cash Refund From Income Taxes | $71.5K | $27.8K | ||
| Income Tax Expense Benefit | -$19.2K | $165.8K | ||
| Income Taxes Paid Net | $217.2K | |||
| Deferred Income Tax Expense Benefit | $549.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $2.6M | $4.1M | -$367.2K | $8.4M | -$6.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.0M | $6.7M | $2.2M | $10.2M | $163.2K |
| Non Cash Lease Expenses | $270.2K | $184.8K | $106.1K | $49.7K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.7M | $4.5M | -$8.0M | $10.1M | |
| Assets | $4.4M | $8.0M | $3.4M | $10.8M | |
| Retained Earnings Accumulated Deficit | -$28.1M | -$24.8M | -$9.2M | ||
| Property Plant And Equipment Net | $138.4K | $216.0K | $178.8K | ||
| Other Receivables Net Current | $159.4K | $83.6K | $106.9K | ||
| Other Assets Current | $377.3K | $222.7K | $164.4K | ||
| Operating Lease Right Of Use Asset | $164.9K | $370.6K | $393.2K | ||
| Operating Lease Liability Current | $168.9K | $240.1K | $154.6K | ||
| Liabilities Noncurrent | $140.9K | $652.9K | $1.3M | ||
| Liabilities Current | $1.7M | $3.2M | $2.5M | ||
| Liabilities And Stockholders Equity | $4.4M | $8.0M | $3.4M | ||
| Liabilities | $1.8M | $3.8M | $3.8M | ||
| Inventory Net | $103.9K | $164.0K | $146.4K | ||
| Finite Lived Intangible Assets Net | $2.4M | $19.0K | $70.8K | ||
| Cash And Cash Equivalents At Carrying Value | $1.0M | $6.7M | $2.2M | ||
| Assets Noncurrent | $2.7M | $661.6K | $724.7K | ||
| Assets Current | $1.8M | $7.3M | $2.7M | ||
| Additional Paid In Capital Common Stock | $30.2M | $28.5M | $8.5M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $591.3K | $428.2K | $289.0K | ||
| Accounts Payable Current | $870.8K | $1.7M | $1.4M | ||
| Accounts Payable And Other Accrued Liabilities Current | $563.5K | $1.1M | $826.2K | ||
| Accounts And Other Receivables Net Current | $109.0K | $111.1K | $74.3K | ||
| Other Assets Noncurrent | $56.0K | $82.0K | |||
| Operating Lease Liability Noncurrent | $135.9K | $241.2K | |||
| Gain Loss On Disposition Of Intangible Assets | -$2.9K | $9.0K | |||
| Stock Issued During Period Value Cashless Exercise Of Common Stock Warrants | $1.00 | ||||
| Repayments Of Related Party Debt | $463.4K | ||||
| Stock Issued During Period Value Purchase Of Assets | $200.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $984.1K | $10.9M | $843.1K | $9.7M |
| Proceeds From Repayments Of Related Party Debt | -$25.0K | $31.8K | -$45.3K | -$11.9K |
| Payments To Acquire Property Plant And Equipment | $63.1K | $134.2K | $186.0K | $15.2K |
| Net Cash Provided By Used In Operating Activities | -$4.4M | -$6.4M | -$2.2M | $975.7K |
| Net Cash Provided By Used In Investing Activities | -$2.4M | -$134.2K | -$186.0K | -$15.2K |
| Net Cash Provided By Used In Financing Activities | $959.0K | $10.9M | -$5.8M | $9.2M |
| Increase Decrease In Other Current Assets | -$101.4K | $32.3K | $210.6K | $2.3K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$1.0M | -$299.9K | $431.8K | $229.8K |
| Increase Decrease In Operating Lease Liability | -$271.6K | -$182.0K | -$105.2K | -$47.4K |
| Increase Decrease In Inventories | -$81.3K | $17.6K | $92.8K | -$22.1K |
| Increase Decrease In Accounts Receivable | $3.0K | $36.8K | $513.00 | -$119.4K |
| Increase Decrease In Accounts Payable Trade | -$800.4K | $312.4K | $748.5K | $298.6K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $163.0K | $139.2K | $217.8K | -$114.4K |
| Increase Decrease In Accrued Income Taxes Payable | -$137.1K | $134.4K | ||
| Share Based Compensation | $414.1K | $9.1M | ||
| Stock Issued During Period Value Share Based Compensation | $9.1M | |||
| Payments For Repurchase Of Common Stock | $6.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 885.8K | 862.3K | 637.1K | 21.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 885.8K | 862.3K | 637.1K | 21.6M |
| Earnings Per Share Diluted | $-3.82 | $-18.09 | $-5.04 | $0.01 |
| Earnings Per Share Basic | $-3.82 | $-18.09 | $-5.04 | $0.01 |
| Shares Issued Via Capitalization Of Amount Due To Director | 4.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Salaries And Wages | $1.6M | $4.0M | $2.4M | $1.0M |
| Depreciation And Amortization | $172.0K | $149.1K | $94.8K | $87.1K |
| Stock Issued During Period Value New Issues | $984.1K | $50.0K | $862.0K | $14.5M |
| Government Incentives | $30.8K | $27.9K | $2.4K | |
| Provision For Other Credit Losses | $13.6K | $106.5K | ||
| Stock Issued During Period Value Public Offering Exercise | $9.1M | |||
| Stock Issued During Period Value Private Placement Exercise | $1.7M | |||
| Stock Issued During Period Ordinary Shares Buy Back | -6.8M | |||
| Reversal Provision For Stock Obsolesces | $20.4K | |||
| Stock Issued During Period Value Other | $100.0K |
Most recent annual filing with the SEC: October 31, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.